RPD-10405-13656
2 vaccinations
2 coded responses
22 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 156 / PA
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Registered in v-safe
-
2021-02-25
Dose 1 — Pfizer-BioNTech
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
-
2021-03-17
Dose 2 — Pfizer-BioNTech
- 2021-03-17
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-23
- 2021-04-28
- 2021-06-16
-
2021-09-15
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pregnant due February 2022 - no complicationsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-21
-
2022-03-17
Survey response — 12 months, dose 2MedDRA: Hospitalisation, Pre-eclampsia, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Postpartum preeclampsia requiring hospitalization - now resolved - otherwise healthy pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-17
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Pregnant due February 2022 - no complications
Release 11 — 12 months, dose 2
Symptoms: Postpartum preeclampsia requiring hospitalization - now resolved - otherwise healthy pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hospitalisation | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release